![]() |
Gynecology, Infectious Disease |
Academic & Clinical Offices |
Academic Office
Emory University School of Medicine
Department of Gynecology and Obstetrics
Division of Gynecologic Oncology
Glenn Building
69 Jesse Hill, Jr., Drive, S.E., Rm 406
Atlanta, GA 30303
Phone · 404-251-8809
Clinical Office Emory University School of Medicine Department of Gynecology & Obstetrics The Emory Clinic Department of Gynecology and Obstetrics 1635 Clifton Road, N.E., 4th Floor Atlanta, GA 30322 Phone 404-778-3401 Fax 404-778-2471 |
Patient Appointments |
Patient Appointments: 404-778-3401 |
Contact Information |
E-mail:kault@emory.edu (Not for medical emergencies or patient use) |
Education |
Medical School Residency Fellowship |
Board Certification |
American Board of Obstetrics and Gynecology |
Awards and Honors |
Dean’s Lecture, Butler University, College of Pharmacy and Health Sciences (2011) American College of Obstetricians and Gynecologists/Curatek Research award in Lower Genital Infections |
Society and Professional Membership |
American Congress of Obstetricians and Gynecologists International Union Against Sexually Transmitted Diseases |
Research Focus |
Dr. Ault's research clinical interests are infectious diseases and women's health. He has been an investigator in a wide variety of translational and clinical research involving vaginitis, gonorrhea, Chlamydia, herpes and human papillomavirus. Recent research projects include HPV vaccine development and immunology, HPV detection in pap smears and the use of molecular techniques to examine the normal vaginal flora. Dr. Ault also participates as an investigator in the Emory Vaccine Center, and this work includes maternal vaccination for influenza. Dr. Ault is a fellow of the American College of Obstetricians and Gynecologists and a fellow of the Infectious Society of America, and is one of the few physicians in the United States with both of these honors. He is also an examiner with the American Board of Obstetrics and Gynecology and the faculty advisor for the Luella Klein Society, a group for Emory medical students with a career interest in women's health. |
Selected Publications
|
Kjaer SK. Sigurdsson K. Iversen OE et al (including Ault KA). A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high – grade cervical and external genital lesions. Cancer Prevention Research. 2009, 2(10):868 – 78. Tamma PD. Ault KA. Del Rio, Carlos. Safety of influenza vaccination during pregnancy. American Journal of Obstetrics and Gynecology. 2009, 201(6):547 – 52. Garland S. Ault KA. Gall SA, et al. Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: a combined analysis of five randomized controlled trails. Obstetrics and Gynecology. 2009,114(6):1179 – 88. King M. Poya H. Rao J. et al (including Ault KA). CXCL13 expression in Chlamydia trachomatis infection of the female reproductive tract. Drugs of Today. 2009, 45 Suppl B:125 – 34. Munoz N. Kjaer SK. Sigurdsson K. et al (including Ault KA). Impact of human papillomavirus (HPV) – 6/11/16/18 vaccine on all HPV – associated genital diseases in young women. Journal of the National Cancer Institute. 2010, 102(5):325 – 39. Forney LJ. Gajer P. Williams CJ. et al (including Ault KA). Comparison of self – collected and physician – collected vaginal swabs for microbiome analysis. Journal of Clinical Microbiology. 2010, 48(5):1741 – 8. FUTURE I/II Study Group, Dillner J, Kjaer SK, Wheeler CM, et al (including Ault KA ). Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. British Medical Journal. 2010, 20;341:c3493. Ravel J. Gajera P. Abdob Z. Schneider GM et al (including Ault KA). Vaginal microbiome of reproductive – age women. Proceedings of the National Academy of Sciences of the United States of America. 2010 Aug 19. www.pnas.org/cgi/doi/10.1073/pnas.1002611107 Ault KA. Joura E. Kjaer S, Iverness E et al. Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine. International Journal of Cancer. 2011, 128(6):1344 – 53. Ault KA. Cervical cancer prevention: better tests, better tools, and more equitable outcomes. J Natl Cancer Inst. 2011 Sep 21;103(18):1352-3. Epub 2011 Sep 6. |